Product Information
Registration Status: ActiveSIN13150P
ROTARIX is approved to be sold in Singapore with effective from 2005-05-10. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN13150P.
This product contains Human Rotavirus Not less than 10 CCID?/dose (1ml) in the form of POWDER, FOR SUSPENSION. It is approved for ORAL use.
This product is manufactured by GlaxoSmithKline Biologicals s.a. in BELGIUM,Fidia Farmaceutici S.P.A. in ITALY, andGlaxo Wellcome Production in FRANCE.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.